MGD-4 is an orally active, Cereblon (CRBN)-dependent IKAROS protein degrader that degrades IKZF1 ( DC 50 =67.2 nM), IKZF2 ( DC 50 =918.2 nM), and IKZF3 ( DC 50 =95.8 nM) in a dose-dependent manner. MGD-4 effectively inhibits the growth of multiple myeloma.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > IKZF Family
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.